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General experimental procedures. Optical rotations were determined with a HITACHI F-4500. ECD 
spectra were measured on a JASCO J-820 spectropolarimeter in MeOH. UV spectra were measured on a 
JASCO V-550. IR spectra were measured on a Perkin Elmer Frontier FT-IR spectrophotometer. NMR 
spectra were recorded on a JEOL JNM-ECX400, Bruker AVANCE III 600, or Bruker AVANCE III 500 
spectrometer. Chemical shifts were referenced to residual solvent peaks (δH 2.49 and δC 39.5 for DMSO-d6, 
δH 2.04 and δC 29.8 for acetone-d6, and δH 3.30 and δC 49.0 for CD3OD. ESI mass spectra were measured 
on a Bruker BioTOF-Q mass spectrometer. 
 
Fungal strain and culture condition. The fungus Aspergillus taichungensis (IBT 19404) was isolated 
from soil in Taiwan. The fungus was cultured on rice medium (5 kg, dried weight) at 25 ˚C for 30 days. 
 
Extraction and isolation. The cultured was extracted with n-BuOH and the extract partitioned with H2O. 
The n-BuOH layer was concentrated and then partitioned between n-hexane and 90% MeOH-H2O. The 
aqueous MeOH fraction (50 g) was subjected to ODS chromatography with 40, 75 (Fr. A), and 95% (Fr. B) 
MeOH-H2O. Fr. A was subjected to SiO2 column chromatography with 50% n-hexane-EtOAc, EtOAc (Fr. 
A1), 50% CH2Cl2-MeOH (Fr. A2), and CH2Cl2-MeOH-H2O (6:4:1) (Fr. A3). Fr. A1 was purified by 
phenyl-hexyl HPLC with 65% MeOH-H2O to afford taichunamide B (2, 1.6 mg), taichunamide C (3, 0.35 
mg), taichunamide E (5, 0.51 mg), taichunamide F (6, 0.47 mg), notoamide V (9, 5.3 mg), 
(+)-6-epi-notoamide F (10, 31 mg), (+)-6-epi-notoamide R (11, 4.8 mg), (+)-6-epi-stephacidin A (13, 160 
mg), (+)-notoamide B (15, 5.3 mg), (-)-stephacidin A (16, 0.82 mg), notoamide C (17, 1.9 mg), notoamide 
Q (18, 0.30 mg), and (+)-6-epi-avrainvillamide (21, 63 mg). Fr. A2 was purified by phenyl-hexyl HPLC 
with 65% MeOH-H2O to afford notoamide D (19, 10 mg). Fr. A3 was subjected to SiO2 chromatography 
with 50% n-hexane-EtOAc, EtOAc (Fr. A3-1), and 20% CH2Cl2-MeOH (Fr. A3-2). Fr. A3-1 was purified 
by NH2 chromatography with 50% CH3CN-H2O followed by phenyl-hexyl HPLC with 65% MeOH-H2O 
and then Asahipak GS-310 HPLC with MeOH to afford taichunamide A (1, 14 mg), taichunamide G (7, 3.3 
mg), (+)-versicolamide B (14, 19 mg), and deoxybrevianamide E (20, 16 mg). Fr. A3-2 was purified by 
NH2 chromatography to afford (+)-notoamide U (8, 140 mg) in an eluent with 97% CH3CN-H2O and 
(+)-versiclamide C (12, 240 mg) in an eluent with 50% CH3CN-H2O. Fr. B was subjected to NH2 
chromatography with 50% CH3CN-H2O to afford taichunamide D (4, 0.50 mg). 
 
Taichunamide A (1): [α]D20 +89 (c 2.4, MeOH); UV (MeOH) λmax (log ε) 204 nm (4.2), 250 nm (sh, 4.1), 
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256 nm (4.1), 264 nm (4.1); ECD (100 µM, MeOH) λmax (Δε) 222 (6.6), 248 (-11), and 272 (13) nm; NMR 
data (DMSO-d6), see Table S1; IR (film) νmax 3357, 2924, 2854, 1678, 1576, 1458, 1398, 1340, 1264, 1208, 
1166, 1111, 1083, 1044, 1026, 897, 818, 798, 742, 689, 580, 504, 410, 387cm-1; NOESY cross peaks, 
H-21/H-10β (δ 1.71); H-19/H-10α (δ 2.63) and H3-23; H-1/H3-23 and H-10α; HRESIMS [M + H]+ m/z 
448.2217 (calcd for C26H30N3O4, 448.2236). 
  
Taichunamide B (2): [α]D20 +99 (c 1.3, MeOH); UV (MeOH) λmax (log ε) 206 nm (4.1), 236 nm (sh, 4.3), 
244 nm (4.4), 254 nm (sh, 4.2), 266 nm (4.1), 276 nm (3.9), 326 nm (3.7), 338 nm (3.6); ECD (200 µM, 
MeOH) λmax (Δε) 214 (sh, 2.1), 222 (4.0), 237 (0.15), 255 (5.3), 284 (-1.5), 290 (sh, -1.3), 321 (1.6), 329 
(1.5) nm; NMR data (DMSO-d6), see Table S2; NMR data (acetone-d6 and CD3OD), see Table S3; IR 
(film) νmax 3420, 3253, 3216, 3178, 3132, 2973, 2926, 2876, 2857, 1678, 1615, 1560, 1570, 1536, 1451, 
1376, 1200, 1122, 1074, 764 cm-1; NOESY cross peaks, H-21/H3-24; H-19/H3-23; HRESIMS [M + H]+ m/z 
446.2064 (calcd for C26H28N3O4, 446.2080). 
 
Taichunamide C (3): [α]D20 +120 (c 0.83, MeOH); UV (MeOH) λmax (log ε) 202 nm (4.2), 230nm (4.0); 
ECD (50 µM, MeOH) λmax (Δε) 203 (-21), 208 (sh, -18), 228 (23), 254 (2.2), 271 (4.0) nm; NMR data 
(DMSO-d6), see Table S4; IR (film) νmax 3358, 2923, 2852, 1680, 1401 cm-1; NOESY cross peaks, 
H-4/H-10β (δ 2.16); H-19/H3-23; H-21/H3-24; H-25/H-30 (δ 4.65); HRESIMS [M + H]+ m/z 494.2256 
(calcd for C27H32N3O6, 494.2291). 
 
Taichunamide D (4): [α]D20 +33 (c 0.42, MeOH); UV (MeOH) λmax (log ε) 204 nm (4.9), 250 nm (4.8), 
288nm (4.4), 296 nm (4.4); ECD (200 µM, MeOH) λmax (Δε) 203 (-1.8), 207 (-1.9), 222 (3.9), 236 (0.05), 
254 (5.3), 273 (1.6), 291 (2.4) nm; NMR data (DMSO-d6), see Table S5; IR (film) νmax 3261, 2924, 2854, 
1683, 1460, 1411, 1361, 1274, 1176, 1135, 1054, 958, 801, 722, 593 cm-1; NOESY cross peaks, 
H-19/H3-23; H-21/H3-24; H-4/H-10α and H10β; H-26/H3-28; H-26/H3-29; HRESIMS [M + Na]+ m/z 
532.1876 (calcd for C27H31N3NaO5S, 532.1882). 
 
Taichunamide E (5): [α]D20 -29 (c 0.36, MeOH); UV (MeOH) λmax (log ε) 204 nm (5.0), 246 nm (5.0), 
280nm (4.6), 292 nm (4.4); ECD (200 µM, MeOH) λmax (Δε) 208 (-4.4), 221 (0.13), 234 (-5.0), 250 (5.6), 
265 (-2.7) nm; NMR data (DMSO-d6), see Table S6; IR (film) νmax 3217, 2923, 2853, 1711, 1458, 1376, 
1285, 1158, 1119 cm-1; NOESY cross peaks, H-4/H-10β, H3-24; H-19/H-10α, H3-23; H-21/H3-24; 
HRESIMS [M + Na]+ m/z 470.2035 (calcd for C26H29N3NaO4, 470.2056).  
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Taichunamide F (6): [α]D20 -3.4 (c 0.041, MeOH); UV (MeOH) λmax (log ε) 202 nm (4.2), 244 nm (sh, 
3.8), 260 nm (3.8), 302 nm (3.5); ECD (200 µM, MeOH) λmax (Δε) 206 (-4.7), 222 (4.4), 241 (-3.4) nm; 
NMR data (DMSO-d6), see Table S7; IR (film) νmax 3363, 2920, 2851, 1680, 1557, 1457, 1391, 1272, 1166, 
1114, 1083, 1025, 905, 825, 720, 515 cm-1; NOESY cross peaks, H-4/H-10; H-19/ H3-23; H-21/H3-24; 
HRESIMS [M + H]+ m/z 494.2295 (calcd for C27H32N3O6, 494.2291). 
 
Taichunamide G (7): [α]D20 +26 (c 0.84, MeOH); UV (MeOH) λmax (log ε) 202 nm (4.3), 238 nm (4.2), 
278nm (3.7), 286 nm (3.7), 328 nm (3.5), 342 nm (3.5); ECD (94.3 µM, MeOH) λmax (Δε) 208 (-9.3), 228 
(3.6), 246 (-4.5) nm; NMR data (DMSO-d6), see Table S8; IR (film) νmax 3273, 2922, 2854, 1688, 1673, 
1654, 1456, 1411, 1261, 1185, 1117, 1058, 942, 898, 807, 739 cm-1; NOESY cross peaks, H-19/H-10 and 
H3-23; H-21/H3-24; HRESIMS [M + Na]+ m/z 484.2240 (calcd for C27H31N3O4Na, 484.2212). 
 
Structure determination of 5 and 7. 
   The planer structure of taichunamide E (5) was identical to those of (+)-versicolamide B (14) and 
(+)-notoamide B (15), which was established by HRESIMS and NMR experiments (Table S6). ECD 
spectrum showed 3R,11S,17S-configuration, and NOE correlations, H-19/H3-23 and H-21/H3-24 (Figure 
S1), showed anti-configuration for H-19/H-21, i.e. 21R-configuration. Therefore, 5 was determined to be 
3-epimer of versicolamide B, which was corresponded to 21-epimer of notoamide B.  
   The molecular formula C27H31N3O4 of 7 was established by HRESIMS, a CH2 unit more than 
notoamide V (9). 1H and 13C NMR spectra of taichunamide G (7) (Table S8) were similar to those of 9 
except for the presence of a methoxyl group (δH 3.42, δC 57.9). HMBC correlation from the methoxyl 
hydrogens to C-10 (δC 76.4) indicated that a hydroxy group in 11 was replaced with a methoxyl group in 7. 
NOE correlations, H-19/H-10, H-21/H3-24 (δ 1.28) and H-19/H3-23 (δ 1.20) (Figure S1), and the positive 











































Figure S1. Key NOE correlations of 1-7. 
 
Conformational analyses of 3, 4, 5, and 7 and ECD calculations for 3 and 6. 
   Conformational searches were performed with Spartan’14 (Ver. 1.1.8 by Wavefunction Inc., Irvine, 
CA) using a commercially available PC (operating system: Windows 7 Professional SP1 64-bit, CPU: 
QuadCore Core i7-3770 processor 3.40 GHz, RAM 8 GB) and DFT calculations were conducted with 
Gaussian09 (Revivion D.01 by Gaussian, Wallingford, CT)[1] with a PC (Operating System: CentOS a 
Linux, CPU: Intel Xeon E5-2603 v3 processors 1.60 GHz, RAM 32 GB). The input structures were 
constructed on a graphical user interface considering the absolute configurations of interest, and were 
subjected to conformational searches with Spartan’14 using MMFF[2] as the force field, in which the 
number of initial conformers was set to 10,000. The obtained most stable 100 conformers were further 
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optimized by the Hartree-Fock (HF) method with 3-21G. The resultant conformers of >1% were finally 
optimized by the density functional theory (DFT) method with B3LYP/6-31G*, giving stable conformers 
for further simulations.  
   For the purpose of ECD calculations for 3 and 6, the dominant conformers obtained were chosen to 
cover >99% of the population from the Boltzmann’s law. Time-dependent density functional theory 
(TDDFT) calculations at the B3LYP/6-31G* level were performed for these conformers, leading to 
rotational strengths for 29 excited states. These rotational strengths were converted into Gaussian curves 
(bandwidth sigma = 3300 cm-1) for the ECD spectrum of each conformer, in which no wavelength 
correction was employed because the corresponding electronic transitions led to the reproduction of the UV 
absorbance peak at 202 nm and the diagnostic positive ECD peak at 225 nm was also reasonably 
reproduced. These spectra were then correctively summed to give the resultant theoretical ECD spectrum 
of 3 and 6 (Figures 3b and 4b). As an accuracy evaluation, TDDFT calculations were also performed with 
the other hybrid functionals CAM-B3LYP and BHandHLYP in the same manner as described above, and 
resulted in the same conclusion in the configuration assignment. 
  
Measurement of Proteasome Inhibitory Activity. 
   The chymotrypsin-like activity of the proteasome was measured with the human 20S proteasome from 
etythrocytes (Boston Biochem, Inc., E-360) and the fluorogenic substrate Suc-Leu-Leu-Val-Tyr-MCA 
(Peptide Institute, Inc). [3] 
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Figure S42. COSY spectrum of 7 in DMSO-d6. 
 




































































Table S1. 1H and 13C NMR data of 1 in DMSO-d6. 
no. δC, mult.   δH, mult., (J in Hz)       COSY                    HMBC 
1    6.29, s  
2   190.7, C 
3 81.3, C 
4 122.0, CH 7.16, d (7.9) 5 3, 6, 8 
5 113.0, CH 6.59, d (7.9) 4 6, 7, 9 
6 153.6, C 
7 114.1, C 
8 147.9, C 
9 134.7, C 
10 25.1, CH2 α 1.71, d (15.5) 10β 3, 9, 12 
  β 2.63, d (15.5) 10α 2, 3, 11, 12, 21 
11 64.1, C   
12 168.4, C 
14 43.9, CH2 α 3.27, m  14β, 15α, 15β 15, 16, 17 
  β 3.32, m 14α, 15α, 15β 15, 16, 17 
15 24.1, CH2 α 1.82, m 14α, 14β, 15β, 16β 14, 16, 17 
  β 1.96, m 14α, 14β, 15α, 16α, 16β 14 
16 28.7, CH2 α 1.82, m 15β, 16β 15, 18 
  β 2.50, m 15α, 15β, 16α 14, 15, 17, 18, 20 
17   67.0, C   
18 172.4, C 
19  7.54, s  11, 12, 17 
20 28.7, CH2 α 1.92, m 20β, 21 11, 17, 23, 24 
  β 2.12, t (13.3) 20α, 21 11, 17, 23, 24 
21 50.1, CH 1.93, m 20α, 20β 22 
22 40.5, C 
23 19.7, CH3 1.35, s  2, 21, 22, 24 
24 27.2, CH3 1.21, s  2, 21, 22, 23 
25 117.4, CH  6.85, d (9.9) 26 6, 7, 8, 26, 27 
26 132.3, CH 5.85, d (9.9) 25 7, 27, 29 
27 76.4, C 
28 27.66, CH3 1.37, s  26, 27, 29 
29 27.74, CH3 1.39, s  26, 27, 28 
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Table S2. 1H and 13C NMR data of 2 in DMSO-d6. 
                            Keto-forma                                                      Enol-forma  
no.   δC, mult.     δH, mult., (J in Hz)       COSY     HMBC  δC, mult.  δH, mult., (J in Hz)   COSY       HMBC 
1  10.42, s  7, 8, 9, 10    
2 164.1, C    172.4, C  
3 172.8, C    157.3, C  
4 126.6, CH 7.92, d (8.7) 5 3, 5, 6, 7, 122.9, CH 7.96, d (8.9) 5 3, 6, 8 
    8 
5 113.7, CH 6.81, d (8.7) 4 6, 7, 9 116.5, CH 7.01, d (8.8) 4 7, 9 
6 154.7, C    153.5, C   
7 108.7, C    114.4, C   
8 135.7, C    146.6, C   
9 121.1, C    114.4, C   
10 111.9, C    107.4, C   
11 68.1, C    69.3, C   
12 167.5, C    172.6, C   
14 43.2, CH2 α 3.33, m 14β, 15α, 15β  43.1, CH2 α 3.36, m 14β, 15α, 15β 
  β 3.23, m 14α, 15α, 15β 16, 17  β 3.48, m  14α, 15α, 15β 15, 16, 17 
15 24.3, CH2 α 1.82, m 14α, 14β, 15β, 16 24.0, CH2 α 1.87, m 14α, 14β, 15β, 
   16β    16β 
  β 1.92, m 14α, 14β, 15α, 16, 17  β 2.32, m 14α, 14β, 15α,  
   16α, 16β    16α, 16β 
16 28.3, CH2 α 1.80, m 15β, 16β 15, 17 27.8, CH2 α 1.88, m 15β, 16β 
  β 2.45, m 15α, 15β, 16α 17, 18, 20  β 2.60, m 15α, 15β, 16α 
17 67.2, C    67.3, C   
18 171.6, C    174.6, C   
19  8.47, s  10, 11, 12,  8.93, s  10, 11, 12,  
    17    17 
20 27.6, CH2 α 1.66, dd 20β, 21 16, 17, 18, 33.6, CH2 α 2.15, m 20β 18 
   (7.7, 12.7)  21, 22 
  β 2.02, dd 20α, 21 11, 16, 17,  β 2.22, m 20α, 21 
  (10.6, 12.3)  18, 21 
21 53.5, CH 2.30, br, t (8.76) 20α, 20β 11, 12, 20, 52.8, CH 2.15, m 20β 2 
          23, 24 
22 43.7, C    43.8, C   
23 21.2, CH3 1.21, s  2, 21, 22, 22.7, CH3 1.18, s  2, 22 
    24 
24 24.8, CH3 1.41, s  2, 21, 22, 26.7, CH3 1.30, s  2, 22 
    23 
25 116.9, CH  7.23, d (10.0) 26 6, 7, 8, 26, 118.2, CH  7.39, d (9.9) 26 6, 27 
     27 
26 129.6, CH 5.90, d (10.0) 25 6, 7, 27, 28, 129.2, CH 5.81, d (9.9) 25 7, 27, 29 
    29 
27 75.9, C    76.4, C   
28 27.4, CH3 1.41, s  27, 29 27.3, CH3 1.42, s  
29 27.4, CH3 1.41, s  27, 28 27.3, CH3 1.42, s 
3-OH      11.27, s  3, 9, 10 
a Keto- and enol-forms were observed in the ratio of 3:1. 
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Table S3. 1H and 13C NMR data of 2 in acetone-d6 and in CD3OD 
               acetone-d6                        CD3OD 
no. δC, mult. δH, mult., (J in Hz)  δC, mult. δH, mult., (J in Hz) 
1 
2 175.1, C  167.4, C 
3 158.9, C  176.5, C 
4 123.8, CH 8.01, d (8.9) 127.8, CH 8.07, d (8.5) 
5 117.3, CH 7.00, d (8.9) 116.1, CH 6.84, d (8.5) 
6 155.4, C  157.7, C 
7 116.1, C  110.1, C 
8 148.6, C  138.7, C 
9 116.1, C  122.1, C 
10 108.3, C   
11 69.1, C   
12 173.6, C   
14 44.8, CH2 3.45, m  44.8, CH2 3.48 (2H), m 
  3.67, m 
15 25.6, CH2 1.99, m 25.4, CH2 2.00, m 
  2.14, m  2.08, m 
16 29.7, CH2 2.05, m 30.0, CH2 1.96, m 
  2.71, m  2.67, m 
17 71.3, C  70.2, C 
18 172.1, C  174.7, C 
19  7.82, br, s 
20 29.0, CH2 2.36, dd (6.7, 10.7) 28.7, CH2 1.88, m 
  2.06, m  2.19, m 
21 54.5, CH 2.74, m 55.4, CH 2.56, m 
22 45.2, C  45.7, C 
23 23.7, CH3 1.35, s 22.4, CH3 1.35, s 
24 28.4, CH3 1.39, s 25.7, CH3 1.52, s 
25 119.3, CH  7.51, d (9.9) 117.0, CH 7.12, d (8.6) 
26 129.5, CH 5.77, d (9.9) 131.3, CH 5.85, d (8.6) 
27 77.5, C  77.7, C 
28 28.3, CH3 1.48, s 28.0, CH3 1.50, s 
29 28.1, CH3 1.46, s 27.6, CH3 1.46, s 
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Table S4. 1H and 13C NMR data of 3 in DMSO-d6. 
 no. δC, mult.      δH, mult., (J in Hz)        COSY          HMBC 
2   107.2, C  
3 73.2, C 
4 126.7, CH 7.21, d (8.4) 5 3, 6, 8 
5 114.9, CH 6.73, d (8.4) 4 6, 7, 9 
6 151.6, C 
7 113.0, C 
8 139.8, C 
9 130.1, C 
10 39.1, C α 2.16, d (15.5) 10β 2, 3, 11, 21 
  β 2.26, d (15.5) 10α 11, 12 
11 59.4, C   
12 168.8, C 
14 43.4, CH2 α 3.22, m  14β, 15α, 15β 15, 16, 17 
  β 3.32, m 14α, 15α, 15β 15, 16 
15 24.0, CH2 α 1.79, m 14α, 14β, 15β, 16α, 16β 
  β 1.93, m 14α, 14β, 15α, 16α, 16β 17 
16 28.1 CH2 α 1.46, m 15α, 15β, 16β 
  β 2.45, m 15α, 15β, 16α 15, 17, 18 
17   66.3, C   
18 172.1, C 
19  7.50, s  11, 12, 17 
20 31.2, CH2 α 1.77, m 20β, 21 17, 18, 21 
  β 2.07, m 20α, 21 17, 21 
21 52.8, CH 1.95, m 20α, 20β 22 
22 39.7, C 
23 26.7, CH3 1.35, s  2, 21, 22, 24 
24 22.7, CH3 0.87, s  2, 21, 22, 23 
25 115.9, CH  6.66, d (10.0) 26 6, 8, 27 
26 132.1, CH 5.84, d (10.0) 25 7, 27, 29 
27 75.9, C 
28 27.2, CH3 1.31, s  26, 27, 29 
29 27.2, CH3 1.40, s  26, 27, 28 
30 88.4, CH2 α 4.57, d (5.4) 30β 8 
  β 4.65, d (5.4) 30α 2, 8 




Table S5. 1H and 13C NMR data of 4 in DMSO-d6.  
no. δC, mult.   δH, mult., (J in Hz)         COSY      HMBC 
2   145.0, C  
3 124.0, C  
4 119.2, CH 7.36, d (8.2) 5 3, 6, 7, 8 
5 115.0, CH 6.85, d (8.2) 4 6, 7, 9 
6 151.8, C 
7 114.0, C 
8 138.0, C 
9 127.3, C 
10 22.0, C α 2.69, d (18.9) 10β 2, 3, 11, 21 
  β 3.81, d (18.9) 10α 2, 3, 11, 12 
11 59.5, C   
12 168.3, C 
14 43.5, CH2 α 3.20, m  14β, 15α, 15β 
  β 3.37, m 14α, 15α, 15β 
15 24.0, CH2 α 1.81, m 14α, 14β, 15β, 16β 
  β 1.97, m 14α, 14β, 15α, 16α, 16β 14, 17 
16 28.1 CH2 α 1.81, m 15β, 16β 14, 15, 17, 18 
  β 2.50, m 15α, 15β, 16α 14, 15, 17, 18 
17   66.8, C   
18 172.3, C 
19  8.74, s  10, 11, 12, 17 
20 31.9, CH2 α 1.87, m 20β, 21 
  β 2.08, m 20α, 21 17, 18, 22 
21 49.6, CH 1.77, m 20α, 20β 20 
22 39.7, C 
23 18.7, CH3 1.41, s  2, 21, 22, 24 
24 25.6, CH3 1.30, s  2, 21, 22, 23 
25 121.2, CH  6.73, d (9.9) 26 6, 7, 8, 27 
26 127.5, CH 5.67, d (9.9) 25 7, 27, 29 
27 75.9, C 
28 25.6, CH3 1.36, s  26, 27, 29 
29 27.8, CH3 1.44, s  26, 27 





Table S6. 1H and 13C NMR data of 5 in DMSO-d6.  
no. δC, mult.       δH, mult., (J in Hz)       COSY                 HMBC 
1  10.61, br s  3, 8, 9 
2 179.7, C  
3 62.2, C 
4 124.0, CH 6.75, d (8.1) 5 6, 8 
5 108.2, CH 6.32, d (8.1) 4 6, 7 
6 152.1, C 
7 104.7, C 
8 137.6, C 
9 126.6, C 
10 33.3, CH α 2.41, d (14.9) 10β 2, 3, 9, 11, 12 
  β 2.53, d (14.9) 10α 3, 9, 11, 12 
11 67.6, C   
12 169.8, C 
14 43.2, CH2 α 3.25, m  14β, 15α, 15β 16 
  β 3.37, m 14α, 15α, 15β 
15 24.4, CH2 α 1.78, m 14α, 14β, 15β, 16β 
  β 1.98, m 14α, 14β, 15α, 16α, 16β 
16 28.7, CH2 α 1.77, m 15β, 16β 14, 15 
  β 2.48, m 15α, 15β, 16α 14 
17 68.2, C   
18 172.4, C 
19  8.69, br s  10, 11 
20 27.2, CH2 α 1.91, dd (10.2, 12.9) 20β, 21 17, 18 
  β 1.63, dd (7.3, 12.9) 20α, 21 21, 22 
21 53.1, CH 2.54, m 20α, 20β 20, 22, 23, 24 
22 48.0, C 
23 19.4, CH3 1.02, s  3, 21, 22, 24 
24 23.1, CH3 0.43, s  2, 3, 22, 23 
25 116.8, CH  6.58, d (9.9) 26 6, 7, 8, 27 
26 130.5, CH 5.74, d (9.9) 25 7, 27, 28, 29 
27 75.8, C 
28 27.4, CH3 1.34, s  26, 27, 29 






Table S7. 1H and 13C NMR data of 6 in DMSO-d6. 
no. δC, mult. δH, mult., (J in Hz)     COSY                HMBC 
2   152.8, C  
3 77.8, C 
4 122.7, CH 7.42, d (8.0) 5 3, 6, 8 
5 115.6, CH 6.82, d (8.0) 4 6, 7, 9 
6 153.7, C 
7 111.5, C 
8 140.2, C 
9 128.8, C 
10 76.4, CH 4.71, s  2, 3, 9, 11, 12, 21 
11 61.4, C   
12 168.2, C 
14 43.7, CH2 3.33 (2H), m  15α, 15β 12, 15, 16, 17 
15 23.9, CH2 α 1.78, m 14, 15β, 16β 
  β 1.95, m 14, 15α, 16α, 16β 16, 17 
16 28.2, CH2 α 1.79, m 15β, 16β 14, 15, 17, 18, 20 
  β 2.50, m 15α, 15β, 16α 15, 17, 18, 20 
17   66.6, C   
18 171.8, C 
19  7.77, br s  10, 11, 12, 17 
20 31.2, CH2 α 1.73, dd (6.5, 13.1) 20β, 21 17, 18, 21, 22 
  β 2.09, dd (10.3, 13.1) 20α, 21 11, 17, 18 
21 41.4, CH 3.06, dd (6.5, 10.3) 20α, 20β 11, 12, 20, 22, 23, 24 
22 36.1, C 
23 13.6, CH3 1.29, s  2, 21, 22, 24 
24 22.0, CH3 1.30, s  2, 21, 22, 23 
25 115.6, CH  7.77, d (9.8) 26 6, 8, 27 
26 132.8, CH 5.91, d (9.8) 25 7, 27, 28 
27 75.8, C 
28 27.4, CH3 1.38, s  26, 27, 29 
29 27.4, CH3 1.40, s  26, 27, 28 
3-OH  6.25, br s  3, 10 




 Table S8. 1H and 13C NMR data of 7 in DMSO-d6. 
no. δC, mult.   δH, mult., (J in Hz)     COSY                HMBC 
1  10.73, br s 
2 141.8, C  
3 106.6, C 
4 117.8, CH 7.31, d (8.4) 5 6, 8 
5 108.8, CH 6.52, d (8.4) 4 6, 7 
6 147.1, C 
7 104.3, C 
8 132.3, C 
9 121.2, C 
10 69.4, CH 4.57, s  2, 3, 9, 11, 12, 21, 10-OMe 
11 62.7, C   
12 168.2, C 
14 43.3, CH2 α 3.27, m  14β, 15α, 15β 
  β 3.40, m 14α, 15α, 15β 15 
15 23.6, CH2 α 1.71, m 14α, 14β, 15β, 16β 16 
  β 1.94, m 14α, 14β, 15α, 16α, 16β 
16 28.6, CH2 α 1.72, m 15β, 16β 15, 20 
  β 2.50, m 15α, 15β, 16α 
17 65.9, C   
18 172.1, C 
19  8.42, br s  10, 11, 17 
20 31.1, CH2 2.11 (2H), br m 21 17, 18, 22 
21 40.5, CH 2.62, dd (4.3, 8.2) 20 22, 23, 24 
22 34.7, C 
23 24.8, CH3 1.20, s  2, 21, 22, 24 
24 29.7, CH3 1.28, s  2, 21, 22, 23 
25 117.8, CH  6.96, d (9.8) 25 6, 7, 8, 27 
26 128.8, CH 5.74, d (9.8) 26 7, 27 
27 74.5, C 
28 26.7, CH3 1.36, s  26, 27, 29 
29 26.7, CH3 1.38, s  27, 28 
10-OMe 57.9, CH3 3.42, s  10 
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Table S9. Calculated distances between designated hydrogens in 3a and 3b.a  
            Bolzmann      Distances (Å) 
 distributions H-25/H30 H-4/H-10 H-19/H3-23 H-21/H3-24 
2R,3R-3a 0.767 2.517 2.737 2.648 2.570 
 0.391 2.511 2.732 2.653 2.571 
 0.079 2.515 2.739 2.627 2.573 
 0.079 2.509 2.732 2.631 2.572 
 0.058 2.681 2.778 2.699 2.524 
2R,3S-3a  0.731 2.360 2.776 2.464 2.397 
 0.269 2.354 2.769 2.470 2.393 
2S,3R-3a  0.765 2.335 2.886 2.570 2.233 
 0.235 2.328 2.879 2.537 2.332 
2S,3S-3a 0.757 2.750 2.414 2.665 2.530 
 0.241 2.753 2.411 2.654 2.533 
2R,3R-3b 0.409 3.611 2.636 2.666 2.563 
 0.281 3.461 2.655 2.682 2.598 
 0.239 3.672 2.622 2.757 2.539 
 0.071 3.467 2.653 2.677 2.597 
2R,3S-3b  0.734 3.291 2.751 2.478 2.342 
 0.266 3.291 2.747 2.479 2.344 
2S,3R-3b  0.763 3.309 2.907 2.863 2.239 
 0.237 3.322 2.911 2.813 2.236 
2S,3S-3b 0.777 3.288 2.972 2.341 2.465 
 0.223 3.299 2.996 2.356 2.458 
a Calculated by Spartan’14 using MMFF for searching low energy conformer, and Hartree-Fock 3-21G and 
B3LYP/6-31G* for structural optimization.  
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Table S10. Calculated distances between designated hydrogens in 6.a 
  Bolzmann   Distance (Å) 
  distributions H-4/H-10 H-19/H-23 H-21/H-24 
3R,10R 0.655 2.989 2.543 2.364 
 0.345 2.988 2.532 2.364 
3R,10S 0.547 3.795 2.691 2.368 
 0.453 3.785 2.678 2.368 
3S,10R 0.634 3.483 2.746 2.360 
 0.290 3.485 2.702 2.363 
 0.076 3.686 2.721 2.356 
3S,10S 0.425 2.902 2.401 2.361 
 0.407 2.893 2.412 2.360 
 0.090 2.908 2.411 2.360 
 0.078 2.898 2.415 2.359 
a Calculated by Spartan’14 using MMFF for searching low energy conformers, and Hartree-Fock 3-21G 
and B3LYP/6-31G* for structural optimization  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
